Abstract
ObjectiveREFLECT is the first randomised, double-masked, placebo-controlled multicentre phase 3 clinical trial that evaluated the efficacy and safety of bilateral intravitreal (IVT) injection of lenadogene nolparvovec in subjects with Leber...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have